David Huang

Majoring in clinical medicine, David later advanced his education through the Advanced Training Course for Excellent Enterprise CEOs (Presidents) at Tsinghua University. With over 30 years of experience in medical and household medical device marketing, he has made significant contributions to the industry.

In 1994, David was a key member of the first promotion team for American Respironics Inc. (now Philips Respironics) in China. He successfully introduced the "Noninvasive Positive Pressure Ventilation" technology to Chinese medical institutions, broadening the scope of mechanical ventilation applications and significantly alleviating patient discomfort.

His career progressed as he took on roles as Sales Director and Marketing Director for several companies within the medical device industry. He was instrumental in promoting products from renowned manufacturers such as HP/Ohmeda, Philips, and GE, as well as specialized manufacturers like Canadian O-TWO ventilators. Guided by industry veterans, David amassed a wealth of experience and market resources, excelling in devising professional and efficient market entry strategies for advanced medical technologies and equipment.

In 2000, David founded his own company, acting as an agent in China to promote medical products from North America, Europe, Japan, South Korea, and other countries. His portfolio includes a diverse range of products such as large-scale fully automatic biochemical analyzers, high sensitivity chemiluminescence immunoassay analyzers, anesthesia machines, operating lights and beds, ICU equipment, ventilators, oxygen concentrators, ultrasound diagnostic instruments, polysomnography devices, EEG machines, infusion and syringe pumps, neonatal care equipment, microwave treatment devices, and medical/household fetal heart rate monitors and nebulizers.

Since 2012, David has expanded his focus to include the medical Internet, big data medical and scientific research practices, and health management systems. He also serves as the general agent for an American animal anesthesia machine in China, gaining a solid understanding of the animal experimental products market.

With the rise of AI and big data applications in healthcare, David began participating in the construction of smart hospitals from 2018 onward. His company now offers products such as intelligent operating rooms, hospital logistics robots, and Supply Processing & Distribution intensive operation services for medical consumables, reflecting his ongoing commitment to innovation and excellence in the medical field.